Metastatic breast cancer is now considered a chronic condition with effective treatments that in many ways allow women to lead a normal or near normal life. Yet, many women live with the fear that their cancer may no longer be responding to medication or the disease has flared in advance of overt clinical symptoms. They believe that a simple bloodtest can effectively monitor medication and help detect recurrences of HER2 tumors. Plus, monitoring helps to reduce anxiety. Therein lies the value of monitoring serum HER2 for women with metastatic HER2 tumors--the possibility of real-time, actionable information and additional peace of mind.

Biotechnology

Martell Diagnostic Laboratories

William Johnson

Martell Diagnostic Laboratories

Org chart

Teams

Advisory and Directorship Team

Leadership Team

Similar companies